Global myeloproliferative neoplasms treatment market - Regional Analysis
Among regions, North America is expected to hold a dominant position in the global myeloproliferative neoplasms treatment market over the forecast period. North America is estimated to hold 38% of the market share in 2023. The global myeloproliferative neoplasms treatment market is expected to witness significant growth in the coming years, driven by the high prevalence of myeloproliferative neoplasms. Increasing prevalence of diseases like polycythemia vera in the region is expected to aid in the market growth over the forecast period. For instance, according to the data published by the National Center for Biotechnology Information (NCBI) in May 20, 2023, the prevalence of polycythemia vera has been estimated to be approximately 22 cases per 100,000 population globally.
Myeloproliferative Neoplasms Treatment Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients